Functional cartilage MRI T2 mapping: evaluating the effect of age and training on knee cartilage response to running.

OBJECTIVE: To characterize effects of age and physical activity level on cartilage thickness and T2 response immediately after running. DESIGN: Institutional review board approval was obtained and all subjects provided informed consent prior to study participation. Cartilage thickness and magnetic resonance imaging (MRI) T2 values of 22 marathon runners and 15 sedentary controls were compared before and after 30 min of running. Runner and control groups were stratified by ageor=46 years. Multi-echo [(Time to Repetition (TR)/Time to Echo (TE) 1500 ms/9-109 ms)] MR images obtained using a 3.0 T scanner were used to calculate thickness and T2 values from the central femoral and tibial cartilage. Baseline cartilage T2 values, and change in cartilage thickness and T2 values after running were compared between the four groups using one-way analysis of variance (ANOVA). RESULTS: After running MRI T2 values decreased in superficial femoral (2 ms-4 ms) and tibial (1 ms-3 ms) cartilage along with a decrease in cartilage thickness: (femoral: 4%-8%, tibial: 0%-12%). Smaller decrease in cartilage T2 values were observed in the middle zone of cartilage, and no change was observed in the deepest layer. There was no difference cartilage deformation or T2 response to running as a function of age or level of physical activity. CONCLUSIONS: Running results in a measurable decrease in cartilage thickness and MRI T2 values of superficial cartilage consistent with greater compressibility of the superficial cartilage layer. Age and level of physical activity did not alter the T2 response to running.

[Will administration of omega-3 unsaturated fatty acids reduce the use of nonsteroidal antirheumatic agents in children with chronic juvenile arthritis?]. / Môze podávanie omega-3 nenasýtených mastných kyselín znízit spotrebu nesteroidných antireumatík u detí s juvenilnou chronickou artritídou?

BACKGROUND: An increased intake of omega-3 polyunsaturated fatty acids (PUFA) in the diet of patients with rheumatoid arthritis has a favourable effect on the course of the disease. The objective of the present work was to assess the effect of such a diet on the daily consumption of non-steroid antirheumatic drugs in children with juvenile chronic arthritis. METHODS AND RESULTS: A group of 23 children with the diagnosis of chronic juvenile arthritis was divided by the method of random numbers into two groups. The first group received in addition to ibuprofen treatment a diet with an increased content of omega-3 PUFA. The second group served as control. In the first group (13 patients, mean age 11 years) in the course of five months treatment the original ibuprofen consumption declined by 17.3% (from a mean value of 28.4 mg/kg/day to 23.4 mg/kg/day), while in the control group (10 children, mean age 9.1 years) there was a decline of 6.5% (from a mean value of 23.7 mg/kg/day to 22.7 mg/kg/day). This difference was statistically significant at the level of 0.05 (P = 0.03). CONCLUSIONS: Despite the statistically significant difference in the decline of daily consumption of the non-steroid antirheumatic drug in the investigated groups of patients and the obvious favourable effect of omega-3 PUFA the mean consumption of the drug remained in the first group after five months of treatment higher (23.4 mg/kg/day) than in the control group (22.4 mg/kg/day).

T-cell receptor BJ gene segment expression in human umbilical cord blood CD4+ and CD8+ T-cell subsets.

By employing RT-PCR-based technology, followed by Southern-blot analysis, patterns of relative TRC BJ gene segment usage in human CD4+ and CD8+ umbilical cord blood T cells (UCT) from ten children were determined in relation to seven recombined TCR BV gene (sub) families (BV 3, 5S1, 6S1-3, 8, 9, 12 and 18). Normal frequency of usage of individual BJ members was observed to be extremely nonrandom. BJ usage in association with each BV was ranked and mean ranking values were calculated for individual BJs. Moreover, BJ family usage and family ranges as well as individual BJ over-representations were determined. In all these aspects of BJ exon expression, CD4+ and CD8+ UCT displayed similar distribution patterns. Comparisons of BJ usage in UCT subpopulations and in the adult peripheral blood lymphocyte (PBL) counterparts were performed and many similarities were observed. However, discrepancies in two parameters were recorded; contrary to observations in PBL, individual BJ over-representations were virtually absent in UCT, and significantly less wide BJ family ranges were demonstrated in CD8+ UCT relative to CD8+ PBL T cells. These differences support the notion that UCT are in a less dynamic state than are PBL T cells. Hence, despite the fact that PBL T cells are subjected to continuous antigenic challenge, the striking resemblance of PBL and UCT with regard to the overall individual relative usage, ranking, mean ranking and family utilisation of BJ gene segments, irrespective of the choice of recombined BV exons, may suggest a relatively nondiscriminatory role for the BJ gene product in antigen recognition as compared to those encoded by the BV, (N) and BD gene segments.

Cerebrospinal fluid of newborn infants contains a deglycosylated form of the intermediate filament nestin.

Nestin is an intermediate filament protein found in CNS progenitor cells. Nestin reappears in CNS tumor cells and reactive astrocytes after CNS injury. In this study we investigated whether nestin could be detected in the cerebrospinal fluid (CSF) of newborn infants and whether expression levels change with gestational age (GA) and/or brain injury. Using Western blot analysis, we examined the expression of nestin in the CSF of newborn infants (GA 25-42 wk) with asphyxia (n = 14), periventricular leukomalacia and peri(intra)ventricular hemorrhage (n = 7), and in a control group (n = 11). Protein extract from the periventricular brain tissue of a 1-wk-old infant was also analyzed. Nestin was detected in all the CSF samples and in the protein extract from the periventricular brain tissue. Although the CSF levels of nestin expression did not change with increasing GA, the asphyxia group had significantly lower levels of nestin in the CSF. An unexpected finding was that brain-derived nestin had an apparent molecular mass of approximately 240 kD, whereas all analyzed CSF samples contained two nestin-immunoreactive proteins at 200 and 220 kD. Experimental deglycosylation of the 240-kD form reduced the molecular mass to 220 kD, indicating that nestin undergoes a specific deglycosylation upon release into the CSF.

Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury.

Neuronal regeneration does generally not occur in the central nervous system (CNS) after injury, which has been attributed to the generation of glial scar tissue. In this report we show that the composition of the glial scar after traumatic CNS injury in rat and mouse is more complex than previously assumed: expression of the intermediate filament nestin is induced in reactive astrocytes. Nestin induction occurs within 48 hours in the spinal cord both at the site of lesion and in degenerating tracts and lasts for at least 13 months. Nestin expression is induced with similar kinetics in the crushed optic nerve. In addition to the expression in reactive astrocytes, we also observed nestin induction within 48 hours after injury in cells close to the central canal in the spinal cord, while nestin expressing cells at later timepoints were found progressively further out from the central canal. This dynamic pattern of nestin induction after injury was mimicked by lacZ expressing cells in nestin promoter/lacZ transgenic mice, suggesting that defined nestin regulatory regions mediate the injury response. We discuss the possibility that the spatiotemporal pattern of nestin expression reflects a population of nestin positive cells, which proliferates and migrates from a region close to the central canal to the site of lesion in response to injury.

Diversity in regulation of adhesion molecules (Mac-1 and L-selectin) in monocytes and neutrophils from neonates and adults.

The surface expression and regulation of the adhesion promoting glycoproteins Mac-1 and L-selectin was measured on monocytes and neutrophils from neonates and adults. A significant decrease in Mac-1 up regulation on both monocytes and neutrophils was found in neonates after both high (10(-7)M) and low (10(-9)M) concentrations of the chemotactic factor N-formyl-methionyl-phenylalanine (FMLP). A significant difference was obtained after incubation for five minutes, which was further enhanced after incubation for 15 minutes. Factors related to bacterial infections, lipopolysaccharides, activated sera (C5a), and aggregated IgG induced an impaired Mac-1 up regulation on both monocytes and neutrophils from neonates compared with adults. The expression of L-selectin was significantly lower on neutrophils from neonates and was less down regulated upon stimulation with a low concentration (10(-12)M) of FMLP. On monocytes from neonates, the expression and down regulation of L-selectin did not differ from monocytes from adults. Mode of delivery did not influence the regulation of Mac-1 and L-selectin in neonates. Diversity in expression and regulation of Mac-1 and L-selectin on monocytes and neutrophils may contribute to the increased susceptibility to infections observed in neonates.